LPTX icon

Leap Therapeutics
LPTX

Overview Fund Activity

41 hedge funds and large institutions have $49.2M invested in Leap Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 11 reducing their positions, and 16 closing their positions.

Holders
41
Holders Change
-8
Holders Change %
-16.33%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
17
Reduced
11
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Two Sigma Advisers
1
Two Sigma Advisers
New York
$1.12M
2
Verition Fund Management
2
Verition Fund Management
Connecticut
$1.01M
3
PIM
3
Platinum Investment Management
Australia
$833K
4
Two Sigma Investments
4
Two Sigma Investments
New York
$788K
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$440K

Top Sellers

1
Alyeska Investment Group
1
Alyeska Investment Group
Illinois
$222K
2
ACM
2
Asymmetry Capital Management
California
$0
3
CH
3
CVI Holdings
Delaware
$0
4
MS
4
Maven Securities
Jersey
$0
5
CCM
5
CAAS Capital Management
New York
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
Jane Street
51
Jane Street
New York
– -$22K -1,064 Closed
CFG
52
Citizens Financial Group
Rhode Island
– -$10K -490 Closed
LC
53
Lindbrook Capital
California
– -$6K -300 Closed
Bank of America
54
Bank of America
North Carolina
– -$6K -300 Closed
1 2
3